NRx Pharmaceuticals (NRXP) Earnings Date, Estimates & Call Transcripts $2.72 +0.13 (+5.02%) Closing price 08/4/2025 04:00 PM EasternExtended Trading$2.73 +0.01 (+0.37%) As of 08/4/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRx Pharmaceuticals Earnings Summary NRx Pharmaceuticals announced Q1 2025 earnings on May 15, 2025, reporting an EPS of -$0.34, which beat analysts' consensus estimates of -$0.40 by $0.06. Quarterly revenue was reported to be $1.14 million, below the consensus estimate of $1.14 million. With a trailing EPS of -$2.01, NRx Pharmaceuticals' earnings are expected to grow next year, from ($1.75) to ($0.08) per share. Upcoming Q2 Earnings DateAug. 13After Market ClosesEstimatedConsensus EPS (May. 15) -$0.40 Actual EPS (May. 15) -$0.34 Beat By $0.06 Actual Revenue (May. 15) $1.14MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)NRXP Upcoming EarningsNRx Pharmaceuticals' Q2 2025 earnings is scheduled for Wednesday, August 13, 2025, with a conference call scheduled on Thursday, August 14, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get NRx Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NRx Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNRXP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. NRx Pharmaceuticals Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($1.75) EPSNext Year EPS Consensus Estimate ($0.08) EPS NRx Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/13/2025(Estimated)--------5/15/2025Q1 2025-$0.40-$0.34+$0.06-$0.34$1.14M$1.14M3/14/2025Q4 2024-$0.20-$0.30 -$0.10-$0.77--8/14/2024Q2 2024-$0.81-$0.75+$0.06-$0.75--5/14/2024Q1 2024--$0.74--$0.74--3/29/2024Q4 2023--$0.50--$0.50--11/13/2023Q3 2023-$11.00-$7.00+$4.00-$0.07--8/14/2023Q2 2023-$14.00-$12.00+$2.00-$0.12-- NRx Pharmaceuticals Earnings - Frequently Asked Questions When is NRx Pharmaceuticals' earnings date? NRx Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on NRXP's earnings history. Did NRx Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, NRx Pharmaceuticals (NASDAQ:NRXP) reported ($0.34) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.40) by $0.06. Learn more on analysts' earnings estimate vs. NRXP's actual earnings. How can I listen to NRx Pharmaceuticals' earnings conference call? The conference call for NRx Pharmaceuticals' latest earnings report can be listened to online. Listen to Conference Call How can I read NRx Pharmaceuticals' conference call transcript? The conference call transcript for NRx Pharmaceuticals' latest earnings report can be read online. Read Transcript How much profit does NRx Pharmaceuticals generate each year? NRx Pharmaceuticals (NASDAQ:NRXP) has a recorded net income of -$25.13 million. NRXP has generated -$2.01 earnings per share over the last four quarters. What is NRx Pharmaceuticals' EPS forecast for next year? NRx Pharmaceuticals' earnings are expected to grow from ($1.75) per share to ($0.08) per share in the next year. More Earnings Resources from MarketBeat Related Companies OGI Earnings EPRX Earnings CTMX Earnings ENGN Earnings KYTX Earnings GALT Earnings ACRS Earnings LYEL Earnings CYBN Earnings SLS Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Why Robinhood Just Added Upside Potential After a Q2 Earnings DipMicrosoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead? This page (NASDAQ:NRXP) was last updated on 8/5/2025 by MarketBeat.com Staff From Our PartnersMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
